Arcoma

8.8

SEK

-1.35 %

Less than 1K followers

ARCOMA

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Ownership

Investor consensus

-1.35%

-13.3%

-14.15%

-18.14%

-25.11%

-34.81%

-7.37%

-52.43%

-33.93%

Arcoma is active in medical technology. The company is a developer and supplier of integrated digital X-ray systems. The company's products offer digital imaging technology combined with technically advanced moving positioning systems. The products are sold through retailers and to a large proportion of OEM customers. Operations are found on a global level with sales mainly concentrated in Europe, Asia, and North America. The head office is located in Växjö.

Market cap

116.03M SEK

Turnover

164.12K SEK

Revenue

156.81M

EBIT %

8.7 %

P/E

10.35

Dividend yield-%

-

Financial calendar

29.4

2025

Interim report Q1'25

14.5

2025

General meeting '25

21.8

2025

Interim report Q2'25

All

Press releases

ShowingAll content types

Press release2/17/2025, 2:20 PM

Carnegie Access: Arcoma: Intervju - Avslutar 2024 med starka marginaler (rapportintervju Q4)

Press release2/14/2025, 7:48 AM

Carnegie Access: Arcoma: Margins expand, but Europe remains under pressure – Q4 review

Regulatory press release6/12/2023, 11:00 AM

Arcoma signs distribution agreement with Canon Korea Inc.

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release5/3/2023, 8:20 PM

Arcoma AB has received certification according to MDR (MAR)

Regulatory press release4/26/2023, 8:45 AM

Arcoma receives order of 10 systems to Thailand

Regulatory press release9/26/2022, 11:00 AM

Arcoma wins tender of 10 million SEK to Czech Republic (MAR)

Regulatory press release8/24/2022, 8:00 AM

Arcoma receives order of 8 systems to Thailand (MAR)

Regulatory press release7/7/2022, 11:00 AM

Arcoma Precision i5 approved for sales in Singapore

Regulatory press release6/27/2022, 11:00 AM

Arcoma wins important procurement in Finland. (MAR)

Regulatory press release11/18/2021, 3:20 PM

Valberedning utsedd inför årsstämma 2022 i Arcoma AB

Regulatory press release12/1/2020, 9:30 AM

Arcoma launches new X-ray system OMNERA 500A on the US market

Regulatory press release8/20/2020, 8:30 AM

Delårsrapport Q2 2020: Stabil försäljning trots Covid-19. Stark lönsamhetsförbättring under första halvåret.

Regulatory press release5/20/2020, 3:15 PM

Kommuniké från årsstämma i Arcoma AB (publ)

Regulatory press release5/20/2020, 1:30 PM

Delårsrapport Q1 2020: Starkt resultat i första kvartalet. EBITDA ökar med 169%.

Regulatory press release5/11/2020, 11:00 AM

Konica Minolta Europa tecknar 5-årigt leverantörsavtal med Arcoma

Regulatory press release4/29/2020, 2:15 PM

Rättelse: Årsredovisning 2019 är nu publicerad

Regulatory press release4/29/2020, 1:30 PM

Årsredovisning 2019 är nu publicerad

Regulatory press release4/21/2020, 5:15 PM

Kallelse till årsstämma i Arcoma Aktiebolag (publ)

Regulatory press release4/20/2020, 1:00 PM

Mattias Rundgren utses till tillförordnad VD

Regulatory press release4/15/2020, 2:00 PM

Susanne Rydberg utses till ny VD för Arcoma AB

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.